Nidec Corporation (NNDNF)
OTCMKTS · Delayed Price · Currency is USD
20.20
0.00 (0.00%)
Jul 31, 2025, 8:00 PM EDT

CTI BioPharma Cash Flow Statement

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 20212017 - 2021
Period Ending
Jun '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2017 - 2021
Net Income
-167,688126,30035,700136,767121,977
Upgrade
Depreciation & Amortization
-138,068131,590119,522104,92489,664
Upgrade
Other Amortization
-----7,138
Upgrade
Loss (Gain) From Sale of Assets
-7520,26215,446-2,247419
Upgrade
Asset Writedown & Restructuring Costs
-----1,592
Upgrade
Loss (Gain) on Equity Investments
-3,1797,1643,9051,461989
Upgrade
Other Operating Activities
--21,363-70,123-50,589-34,412-32,249
Upgrade
Change in Accounts Receivable
--30,042-2,9104,446-68,540-28,979
Upgrade
Change in Inventory
--4,13821,374-27,485-114,179-9,416
Upgrade
Change in Accounts Payable
-32,735-4,312-61,27465,14468,252
Upgrade
Change in Other Net Operating Assets
--1,77491,421103,8146,076-459
Upgrade
Operating Cash Flow
-284,428320,766143,48594,994219,156
Upgrade
Operating Cash Flow Growth
--11.33%123.55%51.05%-56.66%30.41%
Upgrade
Capital Expenditures
--120,711-112,049-137,814-98,580-88,911
Upgrade
Sale of Property, Plant & Equipment
-9,35517,5445,9509,6953,401
Upgrade
Cash Acquisitions
--4,279----5,451
Upgrade
Sale (Purchase) of Intangibles
--28,118-16,391-15,924-16,641-11,015
Upgrade
Other Investing Activities
--3,502-42,657-17,155-7,0711,408
Upgrade
Investing Cash Flow
--147,255-153,553-164,943-112,597-100,568
Upgrade
Short-Term Debt Issued
-50,867-26,55493,380-
Upgrade
Long-Term Debt Issued
-71,78750,000196,00920,000114,900
Upgrade
Total Debt Issued
-122,65450,000222,563113,380114,900
Upgrade
Short-Term Debt Repaid
---118,576---89,209
Upgrade
Long-Term Debt Repaid
--145,197-70,697-144,783-82,515-112,108
Upgrade
Total Debt Repaid
--145,197-189,273-144,783-82,515-201,317
Upgrade
Net Debt Issued (Repaid)
--22,543-139,27377,78030,865-86,417
Upgrade
Repurchase of Common Stock
--7,784-1,028-53,578-57,496-128
Upgrade
Common Dividends Paid
--45,969----35,145
Upgrade
Dividends Paid
--45,969-40,227-40,426-35,132-35,145
Upgrade
Other Financing Activities
--3,897-1,029-3,014-2,630-14,501
Upgrade
Financing Cash Flow
--80,193-181,557-19,238-64,393-136,191
Upgrade
Foreign Exchange Rate Adjustments
--36,71945,25127,13962,12730,141
Upgrade
Miscellaneous Cash Flow Adjustments
-8,973----
Upgrade
Net Cash Flow
-29,23430,907-13,557-19,86912,538
Upgrade
Free Cash Flow
-163,717208,7175,671-3,586130,245
Upgrade
Free Cash Flow Growth
--21.56%3580.43%--270.82%
Upgrade
Free Cash Flow Margin
-6.28%8.89%0.25%-0.19%8.05%
Upgrade
Free Cash Flow Per Share
-142.50181.624.93-3.07111.18
Upgrade
Cash Interest Paid
-21,27020,22111,3574,9135,396
Upgrade
Cash Income Tax Paid
-84,08670,70652,16234,32427,905
Upgrade
Levered Free Cash Flow
-102,21547,890-64,744-56,83774,449
Upgrade
Unlevered Free Cash Flow
-117,00260,600-56,918-53,57077,960
Upgrade
Change in Net Working Capital
-22,36244,29978,904150,45220,036
Upgrade
Updated Jan 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.